# Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life

> **NCT02839291** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 148 (actual)

## Conditions studied

- Tumor With Bone Metastasis

## Interventions

- **OTHER:** quality of life questionaries
- **DRUG:** intravenous or oral bone antiresorptive treatments

## Key facts

- **NCT ID:** NCT02839291
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-06-14
- **Primary completion:** 2024-02-05
- **Final completion:** 2025-01-31
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839291, "Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02839291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*